188 related articles for article (PubMed ID: 24667650)
1. ERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells.
Sengupta D; Bhargava DK; Dixit A; Sahoo BS; Biswas S; Biswas G; Mishra SK
Br J Cancer; 2014 Apr; 110(8):2144-58. PubMed ID: 24667650
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
3. NEDDylation negatively regulates ERRβ expression to promote breast cancer tumorigenesis and progression.
Naik SK; Lam EW; Parija M; Prakash S; Jiramongkol Y; Adhya AK; Parida DK; Mishra SK
Cell Death Dis; 2020 Aug; 11(8):703. PubMed ID: 32839427
[TBL] [Abstract][Full Text] [Related]
4. BCAS2 Enhances Carcinogenic Effects of Estrogen Receptor Alpha in Breast Cancer Cells.
Salmerón-Hernández Á; Noriega-Reyes MY; Jordan A; Baranda-Avila N; Langley E
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813351
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2.
Qi C; Zhu YT; Chang J; Yeldandi AV; Rao MS; Zhu YJ
Biochem Biophys Res Commun; 2005 Mar; 328(2):393-8. PubMed ID: 15694360
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-related Receptor β Reduces the Subnuclear Mobility of Estrogen Receptor α and Suppresses Estrogen-dependent Cellular Function.
Tanida T; Matsuda KI; Yamada S; Hashimoto T; Kawata M
J Biol Chem; 2015 May; 290(19):12332-45. PubMed ID: 25805499
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
9. Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer.
Yu S; Wong YC; Wang XH; Ling MT; Ng CF; Chen S; Chan FL
Oncogene; 2008 May; 27(23):3313-28. PubMed ID: 18071305
[TBL] [Abstract][Full Text] [Related]
10. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
11. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
12. RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation.
Liu Z; Zhang J; Xu J; Yang H; Li X; Hou Y; Zhao Y; Xue M; Wang B; Yu N; Yu S; Niu G; Wu G; Li X; Wang H; Zhu J; Zhuang T
J Cell Mol Med; 2018 Sep; 22(9):4161-4170. PubMed ID: 29974997
[TBL] [Abstract][Full Text] [Related]
13. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-related receptors alpha, beta and gamma expression and function is associated with transcriptional repressor EZH2 in breast carcinoma.
Kumari K; Adhya AK; Rath AK; Reddy PB; Mishra SK
BMC Cancer; 2018 Jun; 18(1):690. PubMed ID: 29940916
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
16. Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.
Seachrist DD; Sizemore ST; Johnson E; Abdul-Karim FW; Weber Bonk KL; Keri RA
Breast Cancer Res; 2017 Jun; 19(1):66. PubMed ID: 28583174
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.
Jiang S; Katayama H; Wang J; Li SA; Hong Y; Radvanyi L; Li JJ; Sen S
Horm Cancer; 2010 Feb; 1(1):11-20. PubMed ID: 21761347
[TBL] [Abstract][Full Text] [Related]
18. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
19. Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
Anbalagan M; Sheng M; Fleischer B; Zhang Y; Gao Y; Hoang V; Matossian M; Burks HE; Burow ME; Collins-Burow BM; Hangauer D; Rowan BG
Mol Cancer Res; 2017 Nov; 15(11):1491-1502. PubMed ID: 28751463
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
